This company listing is no longer active
4550 Stock Overview
Nissui Pharmaceutical Co., Ltd. produces, sells, imports, and exports culture media and diagnostics for medical institutions, research organizations, and food industries in Japan and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Nissui Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,714.00 |
| 52 Week High | JP¥1,745.00 |
| 52 Week Low | JP¥937.00 |
| Beta | -0.22 |
| 1 Month Change | 0.29% |
| 3 Month Change | 0.29% |
| 1 Year Change | 77.07% |
| 3 Year Change | 32.36% |
| 5 Year Change | 16.52% |
| Change since IPO | 58.83% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4550 | JP Medical Equipment | JP Market | |
|---|---|---|---|
| 7D | 0.2% | 1.4% | -2.6% |
| 1Y | 77.1% | 10.7% | 28.4% |
Return vs Industry: 4550 exceeded the JP Medical Equipment industry which returned -4.1% over the past year.
Return vs Market: 4550 exceeded the JP Market which returned -1.1% over the past year.
Price Volatility
| 4550 volatility | |
|---|---|
| 4550 Average Weekly Movement | 0.7% |
| Medical Equipment Industry Average Movement | 3.9% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in JP Market | 8.2% |
| 10% least volatile stocks in JP Market | 2.2% |
Stable Share Price: 4550 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4550's weekly volatility (1%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1935 | 239 | Tokuya Ono | www.nissui-pharm.co.jp |
Nissui Pharmaceutical Co., Ltd. produces, sells, imports, and exports culture media and diagnostics for medical institutions, research organizations, and food industries in Japan and internationally. It offers in vitro diagnostics and medical devices; culture media for microbiological testing; products for antimicrobial susceptibility tests, microorganism identification, and immunological tests; and quality control serum, which is used for ensuring the accuracy of clinical diagnoses. In addition,, the company provides microbiological testing products for food poisoning detection; immunosorbent assays for the detection of allergies to food items, such as eggs, wheat, milk, shrimp, crabs, buckwheat, peanuts, etc.; and culture media and reagents for regenerative medicine.
Nissui Pharmaceutical Co., Ltd. Fundamentals Summary
| 4550 fundamental statistics | |
|---|---|
| Market cap | JP¥16.87b |
| Earnings (TTM) | JP¥1.01b |
| Revenue (TTM) | JP¥17.18b |
16.7x
P/E Ratio1.0x
P/S RatioIs 4550 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4550 income statement (TTM) | |
|---|---|
| Revenue | JP¥17.18b |
| Cost of Revenue | JP¥11.72b |
| Gross Profit | JP¥5.46b |
| Other Expenses | JP¥4.45b |
| Earnings | JP¥1.01b |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 102.73 |
| Gross Margin | 31.80% |
| Net Profit Margin | 5.88% |
| Debt/Equity Ratio | 0% |
How did 4550 perform over the long term?
See historical performance and comparison